HK1022265A1 - Biodegradable microparticles for the sustained delivery of therapeutic drugs - Google Patents

Biodegradable microparticles for the sustained delivery of therapeutic drugs

Info

Publication number
HK1022265A1
HK1022265A1 HK00101153A HK00101153A HK1022265A1 HK 1022265 A1 HK1022265 A1 HK 1022265A1 HK 00101153 A HK00101153 A HK 00101153A HK 00101153 A HK00101153 A HK 00101153A HK 1022265 A1 HK1022265 A1 HK 1022265A1
Authority
HK
Hong Kong
Prior art keywords
sustained delivery
therapeutic drugs
biodegradable microparticles
relates
present
Prior art date
Application number
HK00101153A
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of HK1022265A1 publication Critical patent/HK1022265A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK00101153A 1997-04-17 2000-02-25 Biodegradable microparticles for the sustained delivery of therapeutic drugs HK1022265A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16
PCT/US1998/007856 WO1998046212A1 (en) 1997-04-17 1998-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Publications (1)

Publication Number Publication Date
HK1022265A1 true HK1022265A1 (en) 2000-08-04

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101153A HK1022265A1 (en) 1997-04-17 2000-02-25 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Country Status (11)

Country Link
EP (1) EP0975334B1 (de)
JP (1) JP2002514215A (de)
AT (1) ATE252375T1 (de)
AU (1) AU7134898A (de)
CA (1) CA2287534C (de)
DE (1) DE69819145T2 (de)
DK (1) DK0975334T3 (de)
ES (1) ES2205481T3 (de)
HK (1) HK1022265A1 (de)
PT (1) PT975334E (de)
WO (1) WO1998046212A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
JP2003519651A (ja) * 2000-01-14 2003-06-24 ブラウン ユニバーシティ リサーチ ファウンデーション 微紛化凍結乾燥粒子
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
US6706289B2 (en) * 2000-10-31 2004-03-16 Pr Pharmaceuticals, Inc. Methods and compositions for enhanced delivery of bioactive molecules
EP1829529A1 (de) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Zusammensetzungen zur kontrollierten Freisetzung von Estradiolmetaboliten
JP2005525403A (ja) * 2002-05-03 2005-08-25 ピーアール ファーマシューティカルズ， インコーポレイテッド エストラジオール代謝産物の徐放性組成物
EP1613272B1 (de) 2003-04-11 2013-12-18 Antriabio, Inc. Verfahren zur herstellung von situs-spezifischen proteinkonjugaten
DE602005009954D1 (de) 2004-05-12 2008-11-06 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
EP1758558B1 (de) 2004-05-12 2013-10-16 Baxter International Inc. Oligonucleotid-haltige mikrokügelchen; ihre verwendung zur herstellung eines medikaments zur behandlung von diabetes typ 1
EP1679065A1 (de) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
WO2008131129A2 (en) 2007-04-17 2008-10-30 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
EP2271324A2 (de) * 2008-05-06 2011-01-12 Glaxo Group Limited Einkapselung biologischer wirkstoffe
US20110311630A1 (en) * 2008-06-09 2011-12-22 Boehringer Ingelheim International Gmbh Novel embedment particles for inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
JP2019528248A (ja) 2016-07-18 2019-10-10 ティシュージェン， インク． 生体分子の立体配座及び構造健全性を維持するための方法及び組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
AU4459196A (en) * 1995-01-23 1996-08-14 Takeda Chemical Industries Ltd. Sustained-release preparation and use

Also Published As

Publication number Publication date
PT975334E (pt) 2004-03-31
WO1998046212A1 (en) 1998-10-22
ATE252375T1 (de) 2003-11-15
EP0975334A1 (de) 2000-02-02
JP2002514215A (ja) 2002-05-14
EP0975334B1 (de) 2003-10-22
ES2205481T3 (es) 2004-05-01
CA2287534C (en) 2004-12-28
AU7134898A (en) 1998-11-11
DE69819145D1 (de) 2003-11-27
DE69819145T2 (de) 2004-08-19
CA2287534A1 (en) 1998-10-22
DK0975334T3 (da) 2004-01-19

Similar Documents

Publication Publication Date Title
HK1022265A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
HK1036969A1 (en) Compounds and compositions for delivering active agents
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
HK1054918A1 (en) Compounds and compositions for delivering active agents
HK1036970A1 (en) Compounds and compositions for delivering active agents.
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
EP1233756A4 (de) Feste träger zur verbesserten verabreichung von wirkstoffen in pharmazeutischen zusammensetzungen
IL149337A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
MY140724A (en) Novel arylethene-sulfonamides
MY138502A (en) Novel alkansulfonamides as endothelin antagonists
EP0817643A4 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
EP1676832A3 (de) Verbindungen und Zusammentsetzungen zur Freisetzung von Aktivstoffen

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090417